Pfizer ABANDONS Bay Area Lab—HUNDREDS of Jobs GONE Remote

A biotech giant is abandoning its South San Francisco research site, marking a turning point for the region long known as a hub for life sciences. The decision, driven by shifting market conditions and rising operational costs, will save the company "hundreds of millions" annually. The move reflects a broader industry trend of consolidation and efficiency-seeking. Residents and workers are reflecting on the implications for the community, particularly middle-aged professionals whose lives are intertwined with the biotech industry. The departure raises questions about the future of scientific discovery and the sense of shared mission that has defined South San Francisco for generations. The company will consolidate operations closer to key sites in Massachusetts and Switzerland. This marks a huge shift for South San Francisco's economy.